Chemours 회사는 북미, 아시아 태평양, 유럽, 중동, 아프리카, 라틴 아메리카에서 성능 화학물질을 공급합니다. 회사는 세 가지 부문을 통해 운영됩니다: 열 및 특수 ...
뉴욕주 법무장관 레티샤 제임스는 3M과 듀폰을 포함한 주요 화학 제조업체들을 상대로, 독성 ‘영구 화학물질’(PFAS)로 주를 오염시켔다고 주장하며 소송을 제기했다. 소송은 이들 회사가 소비자와 규제기관을 오도하면서 수십 년 동안 건강 및 환경상의 위험을 의도적으로 만들어 왔다고 밝혔다. 제임스는 정화(청소) 노력에 대한 보상, 손해배상, 재정적 제재, 그리고 충분한 경고 없이 유해 PFAS 제품을 판매하는 것을 금지하기 위한 조치를 요구하고 있다.
뉴욕주 법무장관 레티샤 제임스는 3M과 듀폰을 포함한 5개 주요 화학 기업을 상대로, 일상 가정용품에서 발견되는 독성 ‘영구 화학물질’(PFAS)로 주를 오염시켰다고 주장하며 소송을 제기했다. 소송은 이들 회사가 심각한 건강 문제와 연관된 제품을 수십 년 동안 알고도 제조·판매하고, 증거를 은폐했으며, 금융 제재, 정화 비용, 명확한 안전 경고를 요구한다고 밝혔다. 주(州)는 이미 PFAS 관련 인프라에 1억 달러가 넘는 비용을 지출했으며, 장기 의료비는 44억 달러에 이를 수 있다고 한다.
뉴욕주 법무장관은 3M, 듀폰 및 여러 다른 화학 기업들을 상대로, 환경을 오염시키고 공중보건을 해친 ‘영구 화학물질’(PFAS)을 이들 회사가 알고도 판매했다고 주장하며 소송을 제기했다. 소송은 이들 기업이 뉴욕에서 환경 정화 활동에 자금을 투입하고 제품의 위험성에 대해 소비자에게 경고하도록 강제하는 것을 목표로 한다. 이번 조치는 듀폰, 케미어스(Chemours), 코르테바(Corteva)가 PFAS 오염과 관련해 최대 11억 달러 규모의 뉴저지 환경 청구를 이전에 합의한 것에 따른 후속 조치다.
케미어스의 페이엣빌 웍스와 챔버스 웍스는 환경적 책임과 생물다양성 노력으로 탠덤 글로벌 컨퍼런스에서 인정을 받았으며, WHC Conservation Certification®에 따른 재인증을 달성했다. 페이엣빌 웍스는 또한 조류 및 수분매개자 기업 보전(Corporate Conservation) 어워드 후보로 지명되어 야생동물 서식지를 보호하겠다는 회사의 노력을 부각했다. 이러한 수상·인정은 실용적인 보전 프로그램을 통해 책임 있는 환경 관리에 대한 케미어스의 헌신과 기업의 책임(Corporate Responsibility) 약속 목표를 진전시키고 있음을 보여준다.
The Chemours Company(CC)는 특수화학 수요가 변화함에 따라 투자자들에게 자사의 전략을 업데이트하고 있다. 티타늄 기술과 플루오르 제품을 주요 생산하는 이 회사는 재무상태표(대차대조표) 중심의 규율, 현금 창출, 그리고 반도체 산업을 위한 고성장 분야의 첨단 플루오르 소재와 같은 영역을 우선하기 위해 포트폴리오를 다듬는 데 집중하고 있다. 이 회사의 주가 성과는 글로벌 산업 및 소비 동향과 밀접하게 연동돼 있다.
뉴욕주 법무장관 레티샤 제임스는 3M과 듀폰을 포함한 주요 화학 제조업체들을 상대로, 독성 ‘영구 화학물질’(PFAS)로 주를 오염시켔다고 주장하며 소송을 제기했다. 소송은 이들 회사가 소비자와 규제기관을 오도하면서 수십 년 동안 건강 및 환경상의 위험을 의도적으로 만들어 왔다고 밝혔다. 제임스는 정화(청소) 노력에 대한 보상, 손해배상, 재정적 제재, 그리고 충분한 경고 없이 유해 PFAS 제품을 판매하는 것을 금지하기 위한 조치를 요구하고 있다.
뉴욕주 법무장관 레티샤 제임스는 3M과 듀폰을 포함한 5개 주요 화학 기업을 상대로, 일상 가정용품에서 발견되는 독성 ‘영구 화학물질’(PFAS)로 주를 오염시켰다고 주장하며 소송을 제기했다. 소송은 이들 회사가 심각한 건강 문제와 연관된 제품을 수십 년 동안 알고도 제조·판매하고, 증거를 은폐했으며, 금융 제재, 정화 비용, 명확한 안전 경고를 요구한다고 밝혔다. 주(州)는 이미 PFAS 관련 인프라에 1억 달러가 넘는 비용을 지출했으며, 장기 의료비는 44억 달러에 이를 수 있다고 한다.
뉴욕주 법무장관은 3M, 듀폰 및 여러 다른 화학 기업들을 상대로, 환경을 오염시키고 공중보건을 해친 ‘영구 화학물질’(PFAS)을 이들 회사가 알고도 판매했다고 주장하며 소송을 제기했다. 소송은 이들 기업이 뉴욕에서 환경 정화 활동에 자금을 투입하고 제품의 위험성에 대해 소비자에게 경고하도록 강제하는 것을 목표로 한다. 이번 조치는 듀폰, 케미어스(Chemours), 코르테바(Corteva)가 PFAS 오염과 관련해 최대 11억 달러 규모의 뉴저지 환경 청구를 이전에 합의한 것에 따른 후속 조치다.
케미어스의 페이엣빌 웍스와 챔버스 웍스는 환경적 책임과 생물다양성 노력으로 탠덤 글로벌 컨퍼런스에서 인정을 받았으며, WHC Conservation Certification®에 따른 재인증을 달성했다. 페이엣빌 웍스는 또한 조류 및 수분매개자 기업 보전(Corporate Conservation) 어워드 후보로 지명되어 야생동물 서식지를 보호하겠다는 회사의 노력을 부각했다. 이러한 수상·인정은 실용적인 보전 프로그램을 통해 책임 있는 환경 관리에 대한 케미어스의 헌신과 기업의 책임(Corporate Responsibility) 약속 목표를 진전시키고 있음을 보여준다.
The Chemours Company(CC)는 특수화학 수요가 변화함에 따라 투자자들에게 자사의 전략을 업데이트하고 있다. 티타늄 기술과 플루오르 제품을 주요 생산하는 이 회사는 재무상태표(대차대조표) 중심의 규율, 현금 창출, 그리고 반도체 산업을 위한 고성장 분야의 첨단 플루오르 소재와 같은 영역을 우선하기 위해 포트폴리오를 다듬는 데 집중하고 있다. 이 회사의 주가 성과는 글로벌 산업 및 소비 동향과 밀접하게 연동돼 있다.
노스캐롤라이나 관계자들이 화학 업체 Chemours와의 최근 EPA 합의를 비판하며, PFAS 오염에 대해 주(州)를 충분히 보상하지 못한 ‘뒤문 거래’라고 지적하고 있다. EPA가 4억5천만 달러 규모의 합의를 발표했음에도 노스캐롤라이나는 민사 벌금에 해당하는 자금을 받지 못하며 PFAS 저감 자금에 대해서는 조건이 불명확한 상황이다. 환경단체와 주(州) 지도부는 PFAS 규제 대응에서 EPA의 접근이 지나치게 관대하며 오히려 후퇴를 의미한다고 주장한다.
노스캐롤라이나 관계자들이 PFAS 오염과 관련해 EPA와 화학 업체 Chemours 간에 이뤄진 합의를 비판하며 이를 ‘뒤문 거래’라고 부르고 있다. 관계자들은 협상에서 주(州)가 배제됐으며, Chemours가 노스캐롤라이나를 포함한 3개 주에 대해 오염 전반에 최대 4억5천만 달러를 투입하겠다고 약속했음에도 충분한 자금을 받지 못할 것이라고 주장한다. 환경단체 역시 EPA가 PFAS 규제에 대해 업계 친화적인 접근을 하고 있다고 비난한다.
Chemours(CC)는 PFAS 방출과 관련해 EPA 및 웨스트버지니아 DEP와 1억1천250만 달러 규모의 합의에 동의했으며, 여기에는 2천250만 달러의 민사 벌금과 15년에 걸친 저감 프로젝트를 위한 9천만 달러가 포함된다. 일부 규제상 노출이 명확해지긴 했지만, 투자자들은 회사의 장기 환경 리스크와 투자 내러티브를 평가할 때 지속적인 재정 부담과 추가적인 PFAS 청구 가능성을 고려해야 한다. 이 회사가 증가한 이자 비용과 환경 지출보다 더 빠르게 이익과 자유현금흐름을 끌어올릴 수 있는지의 여부가 핵심이 될 것이다.
Chemours has agreed to a $450 million federal settlement to address PFAS contamination at four facilities, including one in South Jersey. The settlement includes a $22.5 million civil penalty, significant investments in pollution reduction and control systems, and $280 million for providing clean drinking water to affected residents. This deal aims to curb future pollution and provide relief to communities impacted by decades of chemical releases.
This article argues that the future of AI development hinges on rethinking infrastructure to address growing concerns about energy consumption, heat management, and water usage. It emphasizes the need for collaboration across industries and with policymakers to adopt more efficient cooling technologies like liquid cooling, and to establish better metrics for resource use and community impact. The author, Denise Dignam, President and CEO of Chemours, asserts that prioritizing efficiency alongside performance will be crucial for the responsible and sustainable scaling of AI.
A $450 million federal settlement between the EPA and Chemours over PFAS contamination is drawing criticism because it provides little direct cleanup relief for North Carolina's Cape Fear River residents. Much of the settlement is for pollution-control programs, and North Carolina is not set to receive the same water remediation as West Virginia and New Jersey, despite residents already having paid millions for filtration systems through water bills. Local advocates and state leaders, including Attorney General Jeff Jackson, argue the deal fails to hold Chemours accountable and burdens residents further.
RBC Capital analyst Arun Viswanathan reiterated a Buy rating on Chemours Company (CC) and set a price target of $26.00, indicating a potential upside from its closing price. The company also received a Moderate Buy consensus from analysts with an average price target of $25.15. This analysis follows the company's latest earnings report, which showed a quarterly revenue of $1.38 billion and a GAAP net loss of $29 million.
This article provides a detailed financial overview of The Chemours Company (CC), including its latest stock performance, key financial metrics, valuation ratios, and insider/institutional ownership. It highlights a recent price drop of 5.61%, with the stock closing at $19.01, and includes various performance indicators over different timeframes, analyst recommendations, and an earnings surprise for the last quarter.
Chemours has reached a $450 million settlement with federal and state officials to address PFAS pollution at its facilities in West Virginia, North Carolina, and New Jersey. The agreement includes a $22.5 million civil penalty and hundreds of millions for projects to reduce PFAS releases, improve pollution control, and provide clean drinking water to affected communities. The settlement aims to cut down future contamination while allowing the company to continue essential PFAS production under tighter controls.
A recent $450 million federal settlement between the Justice Department, EPA, and Chemours over PFAS pollution has drawn significant criticism from North Carolina officials and environmental groups. Critics, including Governor Josh Stein and Attorney General Jeff Jackson, allege the agreement was a "backroom deal" that largely excluded North Carolina, despite Chemours' Fayetteville facility being a major source of PFAS in the Cape Fear River basin. Environmental advocates also raise concerns about the actual financial commitment from Chemours within the settlement and the EPA's recent actions regarding PFAS regulations.
Chemours (CC) has agreed to a significant PFAS settlement, including a US$22.5 million civil penalty and US$90 million for long-term mitigation, which is expected to clarify its long-term liabilities. Despite a strong year-to-date share price increase of 64.41%, momentum has slowed, and the stock is still considered 24% undervalued with a fair value estimate of $26.33. The settlement improves earnings visibility and free cash flow conversion by reducing a major overhang of litigation risk.
This article announces the filing of a Form 4 for Chemours Co on July 1st. It also presents various financial market data including indices, commodities, bonds, and stock performances. The content is primarily a data feed from Investing.com, providing real-time financial updates.
Chemours director Courtney Mather was granted 1,401 deferred stock units as part of her board compensation. These units, valued at $20.52 each, are economically equivalent to Chemours common stock and increase her total deferred holdings to 8,983.8481 units. The deferred stock units will become payable in shares of common stock in the first month after her termination of service as a director, serving as long-term, non-cash compensation.
North Carolina Governor Josh Stein and Attorney General Jeff Jackson have strongly criticized a proposed settlement between the EPA and Chemours regarding PFAS contamination. They assert that the deal, reached without consulting NC officials, disproportionately benefits West Virginia, leaving North Carolina with minimal resources despite being significantly affected by GenX contamination. Both officials emphasized that the agreement fails to adequately address the extensive environmental damage caused by Chemours in North Carolina and that the state will continue to pursue litigation against the company.
Mizuho has adjusted its price target for Chemours (CC) to $25 from $30, while maintaining an Outperform rating on the stock. The article, published by MT Newswires, provides this analyst recommendation but the full content is reserved for members.
This page from TradingView provides financial information specifically focusing on the "Price to sales forward" metric for The Chemours Company (NYSE: CC). It appears to be a stub or data-focused page without detailed analytical text, primarily displaying the value and change of this financial metric, along with standard navigation and platform information.
Chemours could pay West Virginia more than $11 million as part of a proposed federal settlement requiring the company to pay $22.5 million in civil penalties for environmental violations, including PFAS discharges at its Washington Works plant. The settlement, which also mandates up to $90 million for PFAS mitigation and clean drinking water provisions, resolves a lawsuit brought by the EPA and West Virginia DEP. Environmental advocates view this as a significant win, shifting accountability to Chemours for contamination from "forever chemicals."
This article displays the "Price to sales forward" value for Chemours Co. (FWB:2CU) on the Frankfurt Stock Exchange. It provides a snapshot of this financial metric and is part of a larger financial data and analysis platform.
This page provides a detailed financial overview of The Chemours Company (CC), including its latest stock performance, key financial metrics, various ratios, and analyst recommendations. It highlights the company's market capitalization, income, sales, dividend information, and ownership details, alongside performance metrics over different timeframes.
The Chemours Company has reached a $450 million settlement with the US EPA and Justice Department regarding PFAS (forever chemicals) discharges. The settlement includes a $22.5 million civil penalty and $90 million for additional projects to reduce PFAS emissions and expand drinking water programs over the next 15 years. This agreement addresses long-standing environmental liability concerns that have impacted Chemours since its spinoff from DuPont.
The Trump administration reached a $452.5 million settlement with Chemours Co. regarding unlawful discharges of PFAS "forever chemicals" in North Carolina, West Virginia, and New Jersey. This marks the first federal enforcement settlement against a PFAS maker, with Chemours facing a $22.5 million civil penalty and committing $90 million over 15 years to reduce PFAS discharges, including $280 million for clean drinking water near affected sites. The settlement, however, has drawn criticism from North Carolina's Attorney General, who called it "an insult" to the state's residents.
Local leaders and advocates in North Carolina are expressing dismay over a $450 million settlement between the EPA, Chemours, and the Department of Justice, which they say lacks transparency and neglects North Carolina's water contamination issues. While some funds are allocated for mitigating chemical discharge in multiple states, only a small portion is for penalty fees, and North Carolina will not receive direct aid for its already polluted Cape Fear River. Environmental groups also highlight perceived conflicts of interest within the EPA and the potential for the settlement to hinder future accountability for Chemours.
The Chemours Company has reached a $450 million settlement with federal and state authorities over violations of environmental laws related to PFAS pollution in West Virginia, North Carolina, and New Jersey. The agreement includes a $22.5 million civil penalty, significant investment in PFAS discharge limits, and provisions for clean drinking water in affected communities. This settlement follows a citizens' lawsuit and addresses a long history of industrial pollution, particularly from the Washington Works facility.
Chemours has reached a $450 million settlement with the U.S. Department of Justice, EPA, and West Virginia Department of Environmental Protection over claims of releasing PFAS "forever chemicals" into rivers from its facilities. The agreement includes a civil penalty, a multiyear program to mitigate toxic substance discharges, a PFAS pollution control system, and funds for clean drinking water in affected communities. This settlement follows a previous federal court order for Chemours to stop PFAS discharge from its Washington Works facility.
Chemours has reached a $450 million settlement with the Trump administration to reduce "forever chemical" pollution from its Wood County plant, including a $22.5 million fine and significant investments in upgrades and clean water initiatives. While environmental groups like the West Virginia Rivers Coalition praise the settlement, future battles are expected over the plant's renewed water discharge permit and proposed weakening of chemical limits by the Trump EPA. The agreement follows years of pollution violations and a federal court order prompted by the Rivers Coalition's lawsuit.
North Carolina officials and environmental groups are criticizing Chemours' proposed $450 million federal settlement over PFAS pollution, arguing that it will do little to benefit the state. Governor Josh Stein expressed concerns that North Carolina may not receive any funds from the deal, despite being one of the three states named in the agreement. Environmental advocates emphasize the need for Chemours and DuPont to fund the cleanup of existing pollution in communities rather than relying on the current settlement terms.
Chemours is facing a proposed settlement of $22.5 million in civil penalties for violating environmental laws by discharging PFAS "forever chemicals" at several facilities, including one in West Virginia. Under the proposal, West Virginia would receive $11.25 million, and Chemours would also be required to spend up to $90 million over 15 years to mitigate PFAS discharges and potentially provide clean drinking water to affected communities. While the settlement resolves allegations without an admission of liability from Chemours, it is seen as a win by environmental advocates for safeguarding water resources and holding polluters accountable.
The Chemours Company has reached a settlement with the U.S. EPA and the West Virginia Department of Environmental Protection (WVDEP) to resolve claims related to PFAS discharges and other compliance issues at three of its facilities. The agreement includes a $22.5 million civil penalty and $90 million in additional mitigation projects over 15 years to reduce PFAS emissions and enhance off-site drinking water programs. This settlement aligns with Chemours' "Pathway to Thrive" strategy, aiming for long-term responsible manufacturing and a 99% reduction in fluorinated organic chemical emissions by 2030.
The Trump administration has reached a $450 million multistate settlement with Chemours to address illegal discharges of "forever chemicals" (PFAS) in West Virginia, North Carolina, and New Jersey. The agreement mandates penalties, cleanup measures, new treatment systems, and the provision of clean drinking water to affected communities. While the Justice Department praises the settlement for protecting public health, North Carolina's attorney general criticizes it as inadequate for communities dealing with GenX contamination.
The U.S. Department of Justice announced a proposed $450 million settlement with chemical manufacturer Chemours over PFAS contamination in three states, including North Carolina. However, North Carolina officials, led by Gov. Josh Stein and Attorney General Jeff Jackson, have criticized the deal as a "backroom deal" that offers virtually nothing for their state, despite North Carolina housing the only GenX-producing facility in the U.S. The settlement funds allocated to North Carolina are considered minuscule compared to the actual costs incurred for PFAS remediation and research, leading to concerns about the state's ability to hold Chemours accountable for ongoing pollution.
Chemours, a spin-off of DuPont, has reached a multi-state settlement with the Justice Department, Environmental Protection Agency, and the West Virginia Department of Environmental Protection. The agreement requires Chemours to pay a $22.5 million civil penalty and implement a multi-year, $90 million program to mitigate PFAS discharges from its facilities in West Virginia, North Carolina, and New Jersey. The total cost of the settlement, including penalties and injunctive relief programs to prevent future contamination and provide clean drinking water, is estimated to exceed $450 million over 15 years.
North Carolina Governor Josh Stein and Attorney General Jeff Jackson are criticizing a proposed federal settlement with Chemours, stating it inadequately addresses PFAS contamination in the Cape Fear region. They argue the deal, which offers $90 million over 15 years for water cleanup in three states, was negotiated without state input and provides no guarantee of significant funding for North Carolina. Local advocacy groups also express suspicion regarding the agreement's lack of accountability.
The Trump administration and West Virginia have reached a proposed $22.5 million settlement with chemical giant Chemours for illegal discharges of PFAS "forever chemicals." The agreement also includes up to $90 million for environmental mitigation projects. While hailed by the Justice Department as a landmark deal, North Carolina, a state significantly impacted by Chemours' pollution, has criticized the agreement as "an insult."
The Trump administration has reached a multi-state settlement with Chemours Co., requiring the chemical giant to pay $450 million to resolve claims related to the illegal discharge of "forever chemicals" (PFAS). The settlement includes a civil penalty of $22.5 million, $90 million over 15 years to mitigate PFAS discharges in West Virginia, North Carolina, and New Jersey, and additional costs for pollution controls and clean drinking water. While the Justice Department hails the agreement as protecting public health, North Carolina's Attorney General criticizes it as an "insult" for not adequately addressing contamination in his state.
The federal government has reached a $450 million settlement with Chemours, a company that produces "forever chemicals" (PFAS), to resolve a water pollution case. The Justice Department, EPA, and the state of West Virginia announced on Wednesday that Chemours will pay a civil penalty, fund a mitigation program, install pollution controls, and provide clean drinking water in communities affected by contamination in West Virginia, North Carolina, and New Jersey. The settlement allows Chemours to continue manufacturing PFAS for critical applications while addressing the environmental and health impacts of its past releases.
The Trump administration has reached a multistate settlement with Chemours Co. for $450 million to resolve violations stemming from illegal discharges of "forever chemicals" (PFAS). The agreement includes a $22.5 million civil penalty and requires Chemours to spend $90 million over 15 years on mitigation efforts, install pollution controls, and provide clean drinking water in West Virginia, North Carolina, and New Jersey. This marks the first federal settlement against a major PFAS manufacturer, though North Carolina's Attorney General criticized it as insufficient.
Chemours has reached a landmark settlement with the federal government regarding PFAS contamination in four states, including North Carolina. The company will pay a $22.5 million civil penalty and invest over $370 million in mitigation and clean water programs, which includes reducing PFAS discharges at its Fayetteville Works facility and providing clean drinking water to affected communities. This agreement marks the first federal settlement specifically addressing "forever chemical" pollution by a manufacturer.
North Carolina Attorney General Jeff Jackson has strongly criticized a proposed consent decree between Chemours and the U.S. Environmental Protection Agency regarding PFAS contamination, calling it an "insult" to eastern NC. Jackson argues the agreement does little for the state, neglects groundwater contamination, and is overly favorable to Chemours, especially compared to an existing state-level decree that has already led to significant emission reductions. He believes the EPA has failed to hold Chemours adequately accountable, highlighting that the state's Department of Justice was not involved in the negotiations.
The Trump administration has finalized a multi-state settlement with Chemours Co. regarding alleged illegal discharges of PFAS "forever chemicals." The agreement requires Chemours to pay a $22.5 million civil penalty and invest an estimated $90 million over 15 years to reduce PFAS contamination in specific regions, with the total value of penalties and cleanup efforts estimated at $450 million. This settlement marks the first time the federal government has resolved enforcement claims against a major PFAS manufacturer.
The Chemours Company has reached a $450 million settlement with the U.S. Department of Justice concerning the release of "forever chemicals" (PFAS) in West Virginia, North Carolina, and New Jersey. This settlement is the first comprehensive agreement by the federal government to address enforcement claims against a manufacturer of these chemicals. Chemours will pay a $22.5 million civil penalty and provide $90 million for PFAS control and removal from drinking water, while also committing to operational improvements at its facilities.
The Trump administration has reached a multi-state settlement with Chemours Co, a chemical giant, to resolve enforcement claims against it for illegal discharges of "forever chemicals" (Pfas). Under the agreement, Chemours will pay $22.5 million in penalties and spend an estimated $450 million in total on mitigation efforts across West Virginia, North Carolina, and New Jersey. This settlement is the first by the federal government against a major Pfas manufacturer and aims to prevent future contamination while allowing Chemours to continue its commercial and military operations.
The Chemours Company (CC) has agreed to a settlement requiring over $450 million for penalties, pollution controls, and community water programs related to PFAS contamination. This landmark agreement provides some clarity on its financial liabilities but does not eliminate all future legal, regulatory, and remediation risks. Chemours must also implement operational changes including reduced PFAS discharges and enhanced monitoring.
The Trump administration has reached a multi-state settlement with Chemours Co. over illegal discharges of "forever chemicals" (PFAS), marking the federal government's first enforcement claim against a PFAS manufacturer. Chemours will pay a civil penalty of $22.5 million and spend $90 million over 15 years to mitigate PFAS discharges in West Virginia, North Carolina, and New Jersey. The total value of penalties and relief programs is estimated at $450 million. The settlement allows Chemours to continue manufacturing PFAS for commercial and military applications while addressing ongoing pollution concerns.
This article provides a technical analysis of Chemours Co (CC), detailing its price momentum score, current support and resistance levels, and the readings from various technical indicators and moving averages. The analysis suggests a neutral signal for the stock based on these indicators, noting the stock is suitable for range-bound swing trading.
The Chemours Co (CC) currently holds an earnings forecast score of 6.80, ranking 45th in the Chemicals industry. Analysts estimate a target price of $15.00, with a high of $19.00 and a low of $13.00, and a general "Hold" rating from 10 analysts. The expected revenue for the next quarter is $1.65 billion, with anticipated EPS of $0.40.
